Skip to main content
Top
Published in: Breast Cancer Research 4/2013

Open Access 01-08-2013 | Research article

HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs)

Authors: Ernestina Marianna De Francesco, Rosamaria Lappano, Maria Francesca Santolla, Stefania Marsico, Arnaldo Caruso, Marcello Maggiolini

Published in: Breast Cancer Research | Issue 4/2013

Login to get access

Abstract

Introduction

Carcinoma-associated fibroblasts (CAFs) play a pivotal role in cancer progression by contributing to invasion, metastasis and angiogenesis. Solid tumors possess a unique microenvironment characterized by local hypoxia, which induces gene expression changes and biological features leading to poor outcomes. Hypoxia Inducible Factor 1 (HIF-1) is the main transcription factor that mediates the cell response to hypoxia through different mechanisms that include the regulation of genes strongly associated with cancer aggressiveness. Among the HIF-1 target genes, the G-protein estrogen receptor (GPER) exerts a stimulatory role in diverse types of cancer cells and in CAFs.

Methods

We evaluated the regulation and function of the key angiogenic mediator vascular endothelial growth factor (VEGF) in CAFs exposed to hypoxia. Gene expression studies, Western blotting analysis and immunofluorescence experiments were performed in CAFs and breast cancer cells in the presence of cobalt chloride (CoCl2) or cultured under low oxygen tension (2% O2), in order to analyze the involvement of the HIF-1α/GPER signaling in the biological responses to hypoxia. We also explored the role of the HIF-1α/GPER transduction pathway in functional assays like tube formation in human umbilical vein endothelial cells (HUVECs) and cell migration in CAFs.

Results

We first determined that hypoxia induces the expression of HIF-1α and GPER in CAFs, then we ascertained that the HIF-1α/GPER signaling is involved in the regulation of VEGF expression in breast cancer cells and in CAFs exposed to hypoxia. We also assessed by ChIP assay that HIF-1α and GPER are both recruited to the VEGF promoter sequence and required for VEGF promoter stimulation upon hypoxic condition. As a biological counterpart of these findings, conditioned medium from hypoxic CAFs promoted tube formation in HUVECs in a HIF-1α/GPER dependent manner. The functional cooperation between HIF-1α and GPER in CAFs was also evidenced in the hypoxia-induced cell migration, which involved a further target of the HIF-1α/GPER signaling like connective tissue growth factor (CTGF).

Conclusions

The present results provide novel insight into the role elicited by the HIF-1α/GPER transduction pathway in CAFs towards the hypoxia-dependent tumor angiogenesis. Our findings further extend the molecular mechanisms through which the tumor microenvironment may contribute to cancer progression.
Appendix
Available only for authorised users
Literature
1.
go back to reference Polyak K, Kalluri R: The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb Perspect Biol. 2010, 2: a003244-10.1101/cshperspect.a003244.CrossRefPubMedPubMedCentral Polyak K, Kalluri R: The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb Perspect Biol. 2010, 2: a003244-10.1101/cshperspect.a003244.CrossRefPubMedPubMedCentral
3.
go back to reference Kalluri R, Zeisberg M: Fibroblasts in cancer. Nature Rev Cancer. 2006, 6: 392-401. 10.1038/nrc1877.CrossRef Kalluri R, Zeisberg M: Fibroblasts in cancer. Nature Rev Cancer. 2006, 6: 392-401. 10.1038/nrc1877.CrossRef
4.
go back to reference Orimo A, Weinberg RA: Stromal fibroblasts in cancer. Cell Cycle. 2006, 5: 1597-1601. 10.4161/cc.5.15.3112.CrossRefPubMed Orimo A, Weinberg RA: Stromal fibroblasts in cancer. Cell Cycle. 2006, 5: 1597-1601. 10.4161/cc.5.15.3112.CrossRefPubMed
5.
go back to reference Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, Sahai E: Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol. 2007, 9: 1392-1400. 10.1038/ncb1658.CrossRefPubMed Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, Sahai E: Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol. 2007, 9: 1392-1400. 10.1038/ncb1658.CrossRefPubMed
6.
go back to reference Shimoda M, Mellody KT, Orimo A: Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Semin Cell Dev Biol. 2009, 21: 19-25.CrossRefPubMed Shimoda M, Mellody KT, Orimo A: Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Semin Cell Dev Biol. 2009, 21: 19-25.CrossRefPubMed
7.
go back to reference Liao D, Johnson RS: Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev. 2007, 26: 281-290. 10.1007/s10555-007-9066-y.CrossRefPubMed Liao D, Johnson RS: Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev. 2007, 26: 281-290. 10.1007/s10555-007-9066-y.CrossRefPubMed
8.
go back to reference Harris AL: Hypoxia-a key regulator factor in tumor growth. Nat Rev Cancer. 2002, 2: 38-47. 10.1038/nrc704.CrossRefPubMed Harris AL: Hypoxia-a key regulator factor in tumor growth. Nat Rev Cancer. 2002, 2: 38-47. 10.1038/nrc704.CrossRefPubMed
9.
go back to reference Rapisarda A, Melillo G: Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies. Drug Resist Updat. 2009, 12: 74-80. 10.1016/j.drup.2009.03.002.CrossRefPubMedPubMedCentral Rapisarda A, Melillo G: Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies. Drug Resist Updat. 2009, 12: 74-80. 10.1016/j.drup.2009.03.002.CrossRefPubMedPubMedCentral
10.
go back to reference Lundgren K, Holm C, Landberg G: Hypoxia and breast cancer: prognostic and therapeutic implications. Cell Mol Life Sci. 2006, 64: 3233-3247.CrossRef Lundgren K, Holm C, Landberg G: Hypoxia and breast cancer: prognostic and therapeutic implications. Cell Mol Life Sci. 2006, 64: 3233-3247.CrossRef
11.
go back to reference Semenza GL: Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 2010, 29: 625-634. 10.1038/onc.2009.441.CrossRefPubMed Semenza GL: Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 2010, 29: 625-634. 10.1038/onc.2009.441.CrossRefPubMed
12.
go back to reference Semenza GL: Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci. 2012, 33: 207-214. 10.1016/j.tips.2012.01.005.CrossRefPubMedPubMedCentral Semenza GL: Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci. 2012, 33: 207-214. 10.1016/j.tips.2012.01.005.CrossRefPubMedPubMedCentral
13.
go back to reference Semenza GL: Oxygen sensing, homeostasis, and disease. N Engl J Med. 2011, 365: 537-547. 10.1056/NEJMra1011165.CrossRefPubMed Semenza GL: Oxygen sensing, homeostasis, and disease. N Engl J Med. 2011, 365: 537-547. 10.1056/NEJMra1011165.CrossRefPubMed
14.
go back to reference Semenza GL, Aganì F, Booth G, Forsythe J, Iyer N, Jiang H, Leung S, Roe R, Wiener C, Yu A: Structural and functional analysis of hypoxia-inducible factor I. Kidney Int. 1997, 51: 553-555. 10.1038/ki.1997.77.CrossRefPubMed Semenza GL, Aganì F, Booth G, Forsythe J, Iyer N, Jiang H, Leung S, Roe R, Wiener C, Yu A: Structural and functional analysis of hypoxia-inducible factor I. Kidney Int. 1997, 51: 553-555. 10.1038/ki.1997.77.CrossRefPubMed
15.
go back to reference Wang GL, Semenza GL: General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA. 1993, 90: 4304-4308. 10.1073/pnas.90.9.4304.CrossRefPubMedPubMedCentral Wang GL, Semenza GL: General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA. 1993, 90: 4304-4308. 10.1073/pnas.90.9.4304.CrossRefPubMedPubMedCentral
16.
go back to reference Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG, Semenza GL: Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood. 2005, 105: 659-669. 10.1182/blood-2004-07-2958.CrossRefPubMed Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG, Semenza GL: Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood. 2005, 105: 659-669. 10.1182/blood-2004-07-2958.CrossRefPubMed
17.
go back to reference Arias-Pulido H, Chaher N, Gong Y, Qualls C, Vargas J, Royce M: Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer. BMC Cancer. 2012, 12: 298-10.1186/1471-2407-12-298.CrossRefPubMedPubMedCentral Arias-Pulido H, Chaher N, Gong Y, Qualls C, Vargas J, Royce M: Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer. BMC Cancer. 2012, 12: 298-10.1186/1471-2407-12-298.CrossRefPubMedPubMedCentral
18.
go back to reference Yu L, Deng L, Li J, Zhang Y, Hu L: The prognostic value of vascular endothelial growth factor in ovarian cancer: A systematic review and meta-analysis. Gynecol Oncol. 2013, 128: 391-396. 10.1016/j.ygyno.2012.11.002.CrossRefPubMed Yu L, Deng L, Li J, Zhang Y, Hu L: The prognostic value of vascular endothelial growth factor in ovarian cancer: A systematic review and meta-analysis. Gynecol Oncol. 2013, 128: 391-396. 10.1016/j.ygyno.2012.11.002.CrossRefPubMed
19.
go back to reference Recchia AG, De Francesco EM, Vivacqua A, Sisci D, Panno ML, Andò S, Maggiolini M: 2011. The G protein coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytes. J Biol Chem. 2011, 286: 10773-10782. 10.1074/jbc.M110.172247.CrossRefPubMedPubMedCentral Recchia AG, De Francesco EM, Vivacqua A, Sisci D, Panno ML, Andò S, Maggiolini M: 2011. The G protein coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytes. J Biol Chem. 2011, 286: 10773-10782. 10.1074/jbc.M110.172247.CrossRefPubMedPubMedCentral
20.
go back to reference Lappano R, Recchia AG, De Francesco EM, Angelone T, Cerra MC, Picard D, Maggiolini M: The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes. PLoS One. 2011, 6: e16631-10.1371/journal.pone.0016631.CrossRefPubMedPubMedCentral Lappano R, Recchia AG, De Francesco EM, Angelone T, Cerra MC, Picard D, Maggiolini M: The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes. PLoS One. 2011, 6: e16631-10.1371/journal.pone.0016631.CrossRefPubMedPubMedCentral
21.
go back to reference Pandey DP, Lappano R, Albanito L, Madeo A, Maggiolini M, Picard D: Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J. 2009, 28: 523-532. 10.1038/emboj.2008.304.CrossRefPubMedPubMedCentral Pandey DP, Lappano R, Albanito L, Madeo A, Maggiolini M, Picard D: Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J. 2009, 28: 523-532. 10.1038/emboj.2008.304.CrossRefPubMedPubMedCentral
22.
go back to reference Chu CY, Chang CC, Prakash E, Kuo ML: Connective tissue growth factor (CTGF) and cancer progression. J Biomed Sci. 2008, 15: 675-685. 10.1007/s11373-008-9264-9.CrossRefPubMed Chu CY, Chang CC, Prakash E, Kuo ML: Connective tissue growth factor (CTGF) and cancer progression. J Biomed Sci. 2008, 15: 675-685. 10.1007/s11373-008-9264-9.CrossRefPubMed
23.
go back to reference Madeo A, Maggiolini M: Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. Cancer Res. 2010, 700: 6036-6046.CrossRef Madeo A, Maggiolini M: Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. Cancer Res. 2010, 700: 6036-6046.CrossRef
24.
go back to reference Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ: HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA. 1998, 95: 2979-2984. 10.1073/pnas.95.6.2979.CrossRefPubMedPubMedCentral Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ: HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA. 1998, 95: 2979-2984. 10.1073/pnas.95.6.2979.CrossRefPubMedPubMedCentral
25.
go back to reference Maggiolini M, Donzé O, Picard D: A non-radioactive method for inexpensive quantitative RT-PCR. Biol Chem. 1999, 380: 695-697.CrossRefPubMed Maggiolini M, Donzé O, Picard D: A non-radioactive method for inexpensive quantitative RT-PCR. Biol Chem. 1999, 380: 695-697.CrossRefPubMed
26.
go back to reference Albanito L, Sisci D, Aquila S, Brunelli E, Vivacqua A, Madeo A, Lappano R, Pandey DP, Picard D, Mauro L, Andò S, Maggiolini M: Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer. Endocrinology. 2008, 149: 3799-3808. 10.1210/en.2008-0117.CrossRefPubMedPubMedCentral Albanito L, Sisci D, Aquila S, Brunelli E, Vivacqua A, Madeo A, Lappano R, Pandey DP, Picard D, Mauro L, Andò S, Maggiolini M: Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer. Endocrinology. 2008, 149: 3799-3808. 10.1210/en.2008-0117.CrossRefPubMedPubMedCentral
27.
go back to reference Lanzen J, Braun RD, Klitzman B, Brizel D, Secomb TW, Dewhirst MW: Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor. Cancer Res. 2006, 66: 2219-2223. 10.1158/0008-5472.CAN-03-2958.CrossRefPubMed Lanzen J, Braun RD, Klitzman B, Brizel D, Secomb TW, Dewhirst MW: Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor. Cancer Res. 2006, 66: 2219-2223. 10.1158/0008-5472.CAN-03-2958.CrossRefPubMed
28.
go back to reference Staton CA, Reed MW, Brown NJ: A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Pathol. 2009, 90: 195-221. 10.1111/j.1365-2613.2008.00633.x.CrossRefPubMedPubMedCentral Staton CA, Reed MW, Brown NJ: A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Pathol. 2009, 90: 195-221. 10.1111/j.1365-2613.2008.00633.x.CrossRefPubMedPubMedCentral
29.
go back to reference Soares R, Guo S, Gärtner F, Schmitt FC, Russo J: 17 beta-estradiol-mediated vessel assembly and stabilization in tumor angiogenesis requires TGF beta and EGFR crosstalk. Angiogenesis. 2003, 6: 271-281.CrossRefPubMed Soares R, Guo S, Gärtner F, Schmitt FC, Russo J: 17 beta-estradiol-mediated vessel assembly and stabilization in tumor angiogenesis requires TGF beta and EGFR crosstalk. Angiogenesis. 2003, 6: 271-281.CrossRefPubMed
30.
go back to reference Semenza G: Angiogenesis in ischemic and neoplastic disorders. Annu Rev Med. 2003, 54: 17-28. 10.1146/annurev.med.54.101601.152418.CrossRefPubMed Semenza G: Angiogenesis in ischemic and neoplastic disorders. Annu Rev Med. 2003, 54: 17-28. 10.1146/annurev.med.54.101601.152418.CrossRefPubMed
31.
go back to reference Ferrara N: Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004, 25: 581-611. 10.1210/er.2003-0027.CrossRefPubMed Ferrara N: Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004, 25: 581-611. 10.1210/er.2003-0027.CrossRefPubMed
32.
go back to reference Semenza GL: Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda). 2004, 19: 176-182. 10.1152/physiol.00001.2004.CrossRef Semenza GL: Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda). 2004, 19: 176-182. 10.1152/physiol.00001.2004.CrossRef
33.
go back to reference Smith HO, Leslie KK, Singh M, Qualls CR, Revankar CM, Joste NE, Prossnitz ER: GPR30: a novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol. 2007, 196: 386.e1-386.e11. 10.1016/j.ajog.2007.01.004.CrossRef Smith HO, Leslie KK, Singh M, Qualls CR, Revankar CM, Joste NE, Prossnitz ER: GPR30: a novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol. 2007, 196: 386.e1-386.e11. 10.1016/j.ajog.2007.01.004.CrossRef
34.
go back to reference Smith HO, Arias-Pulido H, Kuo DY, Howard T, Qualls CR, Lee SJ, Verschraegen CF, Hathaway HJ, Joste NE, Prossnitz ER: GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol. 2009, 114: 465-471.CrossRefPubMedPubMedCentral Smith HO, Arias-Pulido H, Kuo DY, Howard T, Qualls CR, Lee SJ, Verschraegen CF, Hathaway HJ, Joste NE, Prossnitz ER: GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol. 2009, 114: 465-471.CrossRefPubMedPubMedCentral
35.
go back to reference Filardo EJ, Graeber CT, Quinn JA, Resnick MB, Giri D, DeLellis RA, Steinhoff MM, Sabo E: Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin Cancer Res. 2006, 12: 6359-6366. 10.1158/1078-0432.CCR-06-0860.CrossRefPubMed Filardo EJ, Graeber CT, Quinn JA, Resnick MB, Giri D, DeLellis RA, Steinhoff MM, Sabo E: Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin Cancer Res. 2006, 12: 6359-6366. 10.1158/1078-0432.CCR-06-0860.CrossRefPubMed
36.
go back to reference Lappano R, Maggiolini M: G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov. 2011, 10: 47-60. 10.1038/nrd3320.CrossRefPubMed Lappano R, Maggiolini M: G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov. 2011, 10: 47-60. 10.1038/nrd3320.CrossRefPubMed
38.
go back to reference Lappano R, Rosano C, De Marco P, De Francesco EM, Pezzi V, Maggiolini M: Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells. Mol Cell Endocrinol. 2010, 320: 162-170. 10.1016/j.mce.2010.02.006.CrossRefPubMed Lappano R, Rosano C, De Marco P, De Francesco EM, Pezzi V, Maggiolini M: Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells. Mol Cell Endocrinol. 2010, 320: 162-170. 10.1016/j.mce.2010.02.006.CrossRefPubMed
39.
go back to reference Lappano R, Santolla MF, Pupo M, Sinicropi MS, Caruso A, Rosano C, Maggiolini M: MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells. Breast Cancer Res. 2012, 14: R12-10.1186/bcr3096.CrossRefPubMedPubMedCentral Lappano R, Santolla MF, Pupo M, Sinicropi MS, Caruso A, Rosano C, Maggiolini M: MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells. Breast Cancer Res. 2012, 14: R12-10.1186/bcr3096.CrossRefPubMedPubMedCentral
40.
go back to reference Santolla MF, Lappano R, De Marco P, Pupo M, Vivacqua A, Sisci D, Abonante S, Iacopetta D, Cappello AR, Dolce V, Maggiolini M: G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts. J Biol Chem. 2012, 287: 43234-43245. 10.1074/jbc.M112.417303.CrossRefPubMedPubMedCentral Santolla MF, Lappano R, De Marco P, Pupo M, Vivacqua A, Sisci D, Abonante S, Iacopetta D, Cappello AR, Dolce V, Maggiolini M: G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts. J Biol Chem. 2012, 287: 43234-43245. 10.1074/jbc.M112.417303.CrossRefPubMedPubMedCentral
41.
go back to reference Vivacqua A, Romeo E, De Marco P, De Francesco EM, Abonante S, Maggiolini M: GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells. Breast Cancer Res Treat. 2012, 133: 1025-1035. 10.1007/s10549-011-1901-8.CrossRefPubMed Vivacqua A, Romeo E, De Marco P, De Francesco EM, Abonante S, Maggiolini M: GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells. Breast Cancer Res Treat. 2012, 133: 1025-1035. 10.1007/s10549-011-1901-8.CrossRefPubMed
42.
go back to reference Pupo M, Pisano A, Lappano R, Santolla MF, De Francesco EM, Abonante S, Rosano C, Maggiolini M: Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts. Environ Health Perspect. 2012, 120: 1177-1182. 10.1289/ehp.1104526.CrossRefPubMedPubMedCentral Pupo M, Pisano A, Lappano R, Santolla MF, De Francesco EM, Abonante S, Rosano C, Maggiolini M: Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts. Environ Health Perspect. 2012, 120: 1177-1182. 10.1289/ehp.1104526.CrossRefPubMedPubMedCentral
43.
go back to reference Lappano R, Rosano C, Santolla MF, Pupo M, De Francesco EM, De Marco P, Ponassi M, Spallarossa A, Ranise A, Maggiolini M: Two novel GPER agonists induce gene expression changes and growth effects in cancer cells. Curr Cancer Drug Targets. 2012, 12: 531-542. 10.2174/156800912800673284.CrossRefPubMed Lappano R, Rosano C, Santolla MF, Pupo M, De Francesco EM, De Marco P, Ponassi M, Spallarossa A, Ranise A, Maggiolini M: Two novel GPER agonists induce gene expression changes and growth effects in cancer cells. Curr Cancer Drug Targets. 2012, 12: 531-542. 10.2174/156800912800673284.CrossRefPubMed
44.
go back to reference Allinen M, Beroukhim R, Cai L, Brennan C, Lathi-Domenici J, Huang AH, Porter D, Hu Am, Chinh L, Richardson A, Schniff S, Seller WR, Polyak K: Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004, 6: 17-32. 10.1016/j.ccr.2004.06.010.CrossRefPubMed Allinen M, Beroukhim R, Cai L, Brennan C, Lathi-Domenici J, Huang AH, Porter D, Hu Am, Chinh L, Richardson A, Schniff S, Seller WR, Polyak K: Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004, 6: 17-32. 10.1016/j.ccr.2004.06.010.CrossRefPubMed
45.
go back to reference Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005, 121: 335-348. 10.1016/j.cell.2005.02.034.CrossRefPubMed Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005, 121: 335-348. 10.1016/j.cell.2005.02.034.CrossRefPubMed
46.
go back to reference Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL: TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science. 2004, 303: 848-851. 10.1126/science.1090922.CrossRefPubMed Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL: TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science. 2004, 303: 848-851. 10.1126/science.1090922.CrossRefPubMed
47.
go back to reference Elenbaas B, Weinberg RA: Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res. 2001, 264: 169-184. 10.1006/excr.2000.5133.CrossRefPubMed Elenbaas B, Weinberg RA: Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res. 2001, 264: 169-184. 10.1006/excr.2000.5133.CrossRefPubMed
49.
go back to reference Cunha GR, Hayward SW, Wang YZ, Ricke WA: Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer. 2003, 107: 1-10. 10.1002/ijc.11335.CrossRefPubMed Cunha GR, Hayward SW, Wang YZ, Ricke WA: Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer. 2003, 107: 1-10. 10.1002/ijc.11335.CrossRefPubMed
50.
go back to reference Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999, 59: 5002-5011.PubMed Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999, 59: 5002-5011.PubMed
51.
go back to reference Tlsty TD: Stromal cells can contribute oncogenic signals. Semin Cancer Biol. 2001, 11: 97-104. 10.1006/scbi.2000.0361.CrossRefPubMed Tlsty TD: Stromal cells can contribute oncogenic signals. Semin Cancer Biol. 2001, 11: 97-104. 10.1006/scbi.2000.0361.CrossRefPubMed
52.
go back to reference Vamesu S: Angiogenesis and tumor histologic type in primary breast cancer patients: an analysis of 155 needle core biopsies. Rom J Morphol Embryol. 2008, 49: 181-188.PubMed Vamesu S: Angiogenesis and tumor histologic type in primary breast cancer patients: an analysis of 155 needle core biopsies. Rom J Morphol Embryol. 2008, 49: 181-188.PubMed
53.
go back to reference Vermeulen PB, van Golen KL, Dirix LY: Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: a review of the current knowledge. Cancer. 2010, 116: 2748-2754. 10.1002/cncr.25169.CrossRefPubMed Vermeulen PB, van Golen KL, Dirix LY: Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: a review of the current knowledge. Cancer. 2010, 116: 2748-2754. 10.1002/cncr.25169.CrossRefPubMed
54.
go back to reference Veikkola T, Alitalo K: VEGFs, receptors and angiogenesis. Sem Cancer Biol. 1999, 9: 211-220. 10.1006/scbi.1998.0091.CrossRef Veikkola T, Alitalo K: VEGFs, receptors and angiogenesis. Sem Cancer Biol. 1999, 9: 211-220. 10.1006/scbi.1998.0091.CrossRef
55.
go back to reference Maity A, Sall W, Koch CJ, Oprysko PR, Evans SM: Low pO2 and beta-estradiol induce VEGF in MCF-7 and MCF-7-5C cells: relationship to in vivo hypoxia. Breast Cancer Res Treat. 2001, 67: 51-60. 10.1023/A:1010662905549.CrossRefPubMed Maity A, Sall W, Koch CJ, Oprysko PR, Evans SM: Low pO2 and beta-estradiol induce VEGF in MCF-7 and MCF-7-5C cells: relationship to in vivo hypoxia. Breast Cancer Res Treat. 2001, 67: 51-60. 10.1023/A:1010662905549.CrossRefPubMed
56.
go back to reference Zhang HT, Craft P, Scott PA, Ziche M, Weich HA, Harris AL, Bicknell R: Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst. 1995, 87: 213-219. 10.1093/jnci/87.3.213.CrossRefPubMed Zhang HT, Craft P, Scott PA, Ziche M, Weich HA, Harris AL, Bicknell R: Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst. 1995, 87: 213-219. 10.1093/jnci/87.3.213.CrossRefPubMed
57.
go back to reference Yoshiji H, Harris SR, Thorgeirsson UP: Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells. Cancer Res. 1997, 57: 3924-3928.PubMed Yoshiji H, Harris SR, Thorgeirsson UP: Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells. Cancer Res. 1997, 57: 3924-3928.PubMed
58.
go back to reference Borgstrom P, Gold DP, Hillan KJ, Ferrara N: Importance of VEGF for breast cancer angiogenesis in vivo: implications from intravital microscopy of combination treatments with an anti-VEGF neutralizing monoclonal antibody and doxorubicin. Anticancer Res. 1999, 19: 4203-4214.PubMed Borgstrom P, Gold DP, Hillan KJ, Ferrara N: Importance of VEGF for breast cancer angiogenesis in vivo: implications from intravital microscopy of combination treatments with an anti-VEGF neutralizing monoclonal antibody and doxorubicin. Anticancer Res. 1999, 19: 4203-4214.PubMed
59.
go back to reference Chen L, Endler A, Shibasaki F: Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors. Exp Mol Med. 2009, 41: 849-857. 10.3858/emm.2009.41.12.103.CrossRefPubMedPubMedCentral Chen L, Endler A, Shibasaki F: Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors. Exp Mol Med. 2009, 41: 849-857. 10.3858/emm.2009.41.12.103.CrossRefPubMedPubMedCentral
60.
go back to reference Ao A, Wang H, Kamarajugadda S, Lu J: Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors. Proc Natl Acad Sci USA. 2008, 105: 7821-7826. 10.1073/pnas.0711677105.CrossRefPubMedPubMedCentral Ao A, Wang H, Kamarajugadda S, Lu J: Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors. Proc Natl Acad Sci USA. 2008, 105: 7821-7826. 10.1073/pnas.0711677105.CrossRefPubMedPubMedCentral
61.
go back to reference Smith HO, Stephens ND, Qualls CR, Fligelman T, Wang T, Lin CY, Burton E, Griffith JK, Pollard JW: The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma. Mol Oncol. 2013, 7: 41-54. 10.1016/j.molonc.2012.07.002.CrossRefPubMed Smith HO, Stephens ND, Qualls CR, Fligelman T, Wang T, Lin CY, Burton E, Griffith JK, Pollard JW: The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma. Mol Oncol. 2013, 7: 41-54. 10.1016/j.molonc.2012.07.002.CrossRefPubMed
62.
go back to reference Patel VH, Chen J, Ramanjaneya M, Karteris E, Zachariades E, Thomas P, Been M, Randeva HS: G-protein coupled estrogen receptor 1 expression in rat and human heart: Protective role during ischaemic stress. Int J Mol Med. 2010, 26: 193-199.PubMed Patel VH, Chen J, Ramanjaneya M, Karteris E, Zachariades E, Thomas P, Been M, Randeva HS: G-protein coupled estrogen receptor 1 expression in rat and human heart: Protective role during ischaemic stress. Int J Mol Med. 2010, 26: 193-199.PubMed
63.
go back to reference Liu SQ, Tefft BJ, Zhang D, Roberts D, Schuster DJ, Wu A: Cardioprotective mechanisms activated in response to myocardial ischemia. Mol Cell Biomech. 2011, 8: 319-338.PubMed Liu SQ, Tefft BJ, Zhang D, Roberts D, Schuster DJ, Wu A: Cardioprotective mechanisms activated in response to myocardial ischemia. Mol Cell Biomech. 2011, 8: 319-338.PubMed
64.
go back to reference Galanis A, Pappa A, Giannakakis A, Lanitis E, Dangaj D, SandaUzopoulos R: Reactive oxygen species and HIF-1 signalling in cancer. Cancer Lett. 2008, 266: 12-20. 10.1016/j.canlet.2008.02.028.CrossRefPubMed Galanis A, Pappa A, Giannakakis A, Lanitis E, Dangaj D, SandaUzopoulos R: Reactive oxygen species and HIF-1 signalling in cancer. Cancer Lett. 2008, 266: 12-20. 10.1016/j.canlet.2008.02.028.CrossRefPubMed
65.
go back to reference Gao P, Zhang H, Dinavahi R, Li F, Xiang Y, Raman V, Bhujwalla ZM, Felsher DW, Cheng L, Pevsner J, Lee LA, Semenza GL, Dang CV: HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell. 2007, 12: 230-238. 10.1016/j.ccr.2007.08.004.CrossRefPubMedPubMedCentral Gao P, Zhang H, Dinavahi R, Li F, Xiang Y, Raman V, Bhujwalla ZM, Felsher DW, Cheng L, Pevsner J, Lee LA, Semenza GL, Dang CV: HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell. 2007, 12: 230-238. 10.1016/j.ccr.2007.08.004.CrossRefPubMedPubMedCentral
66.
go back to reference Dewhirst MW, Cao Y, Moeller B: Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer. 2008, 8: 425-437. 10.1038/nrc2397.CrossRefPubMedPubMedCentral Dewhirst MW, Cao Y, Moeller B: Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer. 2008, 8: 425-437. 10.1038/nrc2397.CrossRefPubMedPubMedCentral
67.
go back to reference Benizri E, Ginouvès A, Berra E: The magic of the hypoxia-signaling cascade. Cell Mol Life Sci. 2008, 65: 1133-1149. 10.1007/s00018-008-7472-0.CrossRefPubMed Benizri E, Ginouvès A, Berra E: The magic of the hypoxia-signaling cascade. Cell Mol Life Sci. 2008, 65: 1133-1149. 10.1007/s00018-008-7472-0.CrossRefPubMed
68.
go back to reference Lappano R, De Marco P, De Francesco EM, Chimento A, Pezzi V, Maggiolini M: Cross-talk between GPER and growth factor signaling. J Steroid Biochem Mol Biol. 2013. Lappano R, De Marco P, De Francesco EM, Chimento A, Pezzi V, Maggiolini M: Cross-talk between GPER and growth factor signaling. J Steroid Biochem Mol Biol. 2013.
Metadata
Title
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs)
Authors
Ernestina Marianna De Francesco
Rosamaria Lappano
Maria Francesca Santolla
Stefania Marsico
Arnaldo Caruso
Marcello Maggiolini
Publication date
01-08-2013
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 4/2013
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3458

Other articles of this Issue 4/2013

Breast Cancer Research 4/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine